Syngene InstaVisit

01.07.21

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities from wherever you are.

Based on pre-recorded video footage of our facilities, the platform allows you to change your perspective, look around and zoom-in/out as you are taken on a guided tour of Syngene’s facilities.

You can have a look around our state-of-the-art R & D centers, and world-class laboratories associated with each operational unit through this platform.

Watch Now!

More Content From Syngene InstaVisit

Solid Dosage/Creams/Ointments

Oral Solid Dose Outsourcing Trends: CMOs Bask in Pill Promise

OSD outsourcing expands as CMOs excel. This is the second of a nine-part series of articles addressing pharmaceutical outsourcing industry trends.

Sponsored Content Released on 03.10.2023
Drug Discovery | R&D

CROs at the High Table of Drug Discovery

Offshoring reaches an inflection point as CROs turn risk-sharing partners in discovery research. This is the first of a nine-part series.

Sponsored Content Released on 01.30.2023
Targeted Protein Degradation

Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.

Literature / Brochures Released on 01.18.2021
Biologics and Manufacturing

Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.

Literature / Brochures Released on 01.15.2021
Your Pre-clinical Toxicology Program Needs a Strategy

At Syngene, we have developed a roadmap across pre-IND, IND and NDA that seamlessly integrate the various pre-clinical studies.

Case Studies Released on 01.14.2021
Chemical Development

Syngene has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.

Literature / Brochures Released on 01.14.2021
The Dedicated Center

Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.

Case Studies Released on 01.13.2021
Clinical Development

Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.

Literature / Brochures Released on 01.13.2021
Proactive COVID-19 Testing

By identifying COVID-19 positive cases early on, particularly those that are asymptomatic, we can restrict further transmission of this deadly virus.

Case Studies Released on 01.12.2021
Commercial Manufacturing

Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates.

Literature / Brochures Released on 01.12.2021
How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective

Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.

Case Studies Released on 01.11.2021
Formulation Development

Syngene supports both development and manufacturing of Drug Products from early to late stage.

Literature / Brochures Released on 01.11.2021
Harnessing Targeted Protein Degradation

Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.

Case Studies Released on 01.08.2021
ICH Stability Studies

One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.

Literature / Brochures Released on 01.08.2021
Oligonucleotides

Syngene's services encompass Therapeutic oligonucleotides, Diagnostic Oligonucleotides, Enzymatic synthesis and analytical services.

Literature / Brochures Released on 01.07.2021

FOLLOW: